twenty-three patients with b-cell non-immunoblastic lymphoma or follicular lymphoma who had a bcl-2 oncogene rearrangement had a poorer response to therapy ( 7 of 23 with complete remission ) than the patients without bcl-2 rearrangement ( 21 of 26 with complete remission ) .
C0004561
b-cell
C0024301
follicular lymphoma